Analysed JASPER THERAPEUTICS INC (JSPR:NASDAQ) News Sources
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
30-03-2026
yahoo.com
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab
29-03-2026
yahoo.com
Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
08-01-2026
yahoo.com
Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
07-01-2026
yahoo.com
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
02-12-2025
yahoo.com
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation
01-12-2025
yahoo.com
What is the current price of JASPER THERAPEUTICS INC (JSPR:NASDAQ)?
The current price of JASPER THERAPEUTICS INC (JSPR:NASDAQ) is $0.96.
JASPER THERAPEUTICS INC (JSPR:NASDAQ) absolute price change since previous trading day?
The absolute price change of JASPER THERAPEUTICS INC (JSPR:NASDAQ) since the previous trading day is $-0.1.
JASPER THERAPEUTICS INC (JSPR:NASDAQ) percentage price change since previous trading day?
The percentage price change of JASPER THERAPEUTICS INC (JSPR:NASDAQ) since the previous trading day is -9.434%.
What is the most recent average sentiment score for JASPER THERAPEUTICS INC (JSPR:NASDAQ)?
The most recent average sentiment score for JASPER THERAPEUTICS INC (JSPR:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for JASPER THERAPEUTICS INC (JSPR:NASDAQ)?
The most recent sentiment for JASPER THERAPEUTICS INC (JSPR:NASDAQ) is .
SEC-8K** Filing Available For JASPER THERAPEUTICS INC (JSPR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.